The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

4

Sep

Hybrid Symposium: Advancing Research with Viral Vectors and mRNA

4 September 2024 13:30 to 16:15 | Seminar
Symposium Flyer

Come learn how viral vectors and mRNA are changing the game in biomedicine! This hybrid afternoon event dives into cutting-edge delivery systems, gene editing tools, therapeutic applications, and more.

Date & Time: 4 September, 13:30 - 16:30

Location: BMC, A10, Segerfalksalen and online

Please note that there are limited spaces/seats available for on-site participants and that this is arranged on a first come, first serve basis. To participate in the symposium, please complete the registration form below before 12:00 am on Tuesday, 3 September, 2024.

Program:

13:30 – 13:35 Welcome address

13:35 – 14:05 Harnessing nanotechnology: nanostraws for gentle mRNA delivery in hematopoietic stem cells – Tyra Bremborg, PhD student, Larsson Group, Lund Stem Cell Center, Lund, Sweden

14:05 – 14:35 Optimizing RNA cocktails for dendritic cell reprogramming – Nejc Arh, PhD student, Pereira Group, Lund Stem Cell Center, Lund, Sweden 

14:35– 14:50 The Merck Functional Genomics Toolbox: RNAi, CRISPR, and Beyond – Marko Sankala, PhD, Scientific Sales Specialist, Merck Life Science 

14:50 – 15:05 Coffee break & discussions

15:05 – 15:35 The role of polymorphic transposable elements in brain development and disease – Vivien Horvath, Postdoc, Jakobsson Group, Lund Stem Cell Center, Lund, Sweden

15:35 – 16:05 Revealing biological insights in psychiatric disorders using recombinant viruses – Navneet A. Vasistha, Assistant Professor, Khodosevich Group, BRIC, Copenhagen Denmark

16:05 – 16:15 Closing remarks

About the Organisers:

The event, sponsored by Merck Life Science, is organised by Cell & Gene Therapy Core Facility at Lund Stem Cell Center, Faculty of Medicine, Lund University.

We are committed to advance research excellence by providing cutting-edge services, tools, and technologies to support the innovative work of research labs. We strive to empower researchers by offering guidance, information and training in key areas such as iPSC, vectors, CRISPR and beyond.

Join us as we explore the potential of mRNA and viral vectors, charting new pathways in basic research!

About the event

Location:

Segerfalksalen, BMC A10 | Sölvegatan 17, 223 62 Lund

Target group:

Students, researchers, clinicians, life science industry professionals

Language:

In English

Contact:

cellandgenetherapy [at] med [dot] lu [dot] se